Cormorant Asset Management, LP Reata Pharmaceuticals Inc Transaction History

Cormorant Asset Management, LP

$1.43 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $2.56 Million - $11.1 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $6.82 Million - $9.75 Million	-68,150 Reduced 40.53%	100,000 $10.1 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $18.1 Million - $35.1 Million	-231,850 Reduced 57.96%	168,150 $23.8 Million
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $9.43 Million - $13.3 Million	-100,000 Reduced 20.0%	400,000 $39.9 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $5.1 Million - $9.23 Million	50,000 Added 11.11%	500,000 $61.8 Million
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $4.68 Million - $8.17 Million	50,000 Added 12.5%	450,000 $43.8 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $11 Million - $15.4 Million	-87,206 Reduced 17.9%	400,000 $62.4 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $40.9 Million - $81.6 Million	-329,194 Reduced 40.32%	487,206 $70.3 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $251,226 - $734,172	-3,369 Reduced 0.41%	816,400 $167 Million
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $970,489 - $1.3 Million	13,619 Added 1.69%	819,769 $65.8 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $14.9 Million - $18 Million	191,150 Added 31.08%	806,150 $76.1 Million
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $3.08 Million - $6.03 Million	-59,251 Reduced 8.79%	615,000 $52.6 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $694,878 - $1.09 Million	14,251 Added 2.16%	674,251 $37.8 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $7.48 Million - $19.3 Million	210,000 Added 46.67%	660,000 $54 Million
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $5 Million - $7.55 Million	250,000 Added 125.0%	450,000 $9.23 Million
Q4 2017 Feb 14, 2018	SELL	$22.39 - $33.27 $4.22 Million - $6.27 Million	-188,574 Reduced 48.53%	200,000 $5.66 Million
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $10.2 Million - $12.4 Million	388,574	388,574 $12.1 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account